Patient Name: Johnathan Miller
Date of Birth: March 5, 1980
Gender: Male
Address: 123 Main Street, Springfield, USA

Medical History Overview
Chief Complaints:

Persistent chest pain for the past 3 months.
Occasional shortness of breath during physical exertion.
Past Medical History:

Hypertension (diagnosed in 2016).
Hyperlipidemia (diagnosed in 2018).
Appendectomy in 2005 (uncomplicated recovery).
COVID-19 infection (March 2021, mild symptoms).
Family History:

Father: Deceased at 67 (myocardial infarction).
Mother: Hypertension, alive at 75.
Sister: Type 2 diabetes, alive at 42.
Social History:

Smoker (10 cigarettes/day for 15 years, quit in 2020).
Occasional alcohol use (1-2 drinks/week).
Sedentary lifestyle.
Medications:

Lisinopril 10 mg daily (for hypertension).
Atorvastatin 20 mg daily (for hyperlipidemia).
Multivitamin daily.
Allergies:

No known drug or food allergies.
Clinical Reports
1. Cardiologist Consultation Report
Date: January 20, 2025
Findings:

Blood pressure: 140/90 mmHg
Heart rate: 85 bpm
ECG: Normal sinus rhythm, no ST-T changes.
Echocardiogram: Mild left ventricular hypertrophy; ejection fraction preserved at 55%.
Impression:

Hypertensive heart disease.
No acute ischemic changes.
Plan:

Increase Lisinopril to 20 mg daily.
Encourage weight loss and regular aerobic exercise.
Schedule a stress test.
2. Stress Test Report
Date: February 1, 2025
Procedure: Bruce Protocol

Patient exercised for 7 minutes.
Achieved 85% of maximum predicted heart rate.
No chest pain during the test.
ECG showed no significant ischemic changes.
Impression:

Functional capacity within normal limits.
Low likelihood of obstructive coronary artery disease.
3. Lipid Panel Report
Date: January 15, 2025

Test	Result	Reference Range
Total Cholesterol	220 mg/dL	<200 mg/dL
LDL Cholesterol	140 mg/dL	<100 mg/dL
HDL Cholesterol	45 mg/dL	>40 mg/dL
Triglycerides	180 mg/dL	<150 mg/dL
Interpretation:

Borderline high cholesterol.
Increased cardiovascular risk due to elevated LDL.
4. Pulmonary Function Test (PFT)
Date: January 18, 2025

FEV1: 85% predicted.
FVC: 90% predicted.
FEV1/FVC Ratio: 0.94 (normal).
Impression:

Normal lung function.
Plan and Recommendations:
Lifestyle Modifications:

Follow a low-sodium, heart-healthy diet (DASH diet).
Engage in at least 150 minutes of moderate-intensity aerobic activity weekly.
Avoid alcohol and completely abstain from tobacco.
Medication Adjustments:

Increase Atorvastatin to 40 mg daily to lower LDL cholesterol.
Maintain Lisinopril 20 mg for blood pressure control.
Follow-Up:

Repeat lipid panel in 3 months.
Follow-up with cardiology in 6 months.